Актонель один-раз-в-месяц 150 мг
Country: Israel
Language: Russian
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
RISEDRONIC ACID AS SODIUM 150 MG
Available from:
SANOFI - AVENTIS ISRAEL LTD
ATC code:
M05BA07
Pharmaceutical form:
FILM COATED TABLETS
Administration route:
PER OS
Manufactured by:
WARNER CHILCOTT DEUTSCHLAND GMBH, GERMANY
Therapeutic group:
RISEDRONIC ACID
Therapeutic indications:
Treatment of postmenopausal osteoporosis.Prevention of postmenopausal osteoporosis.
Authorization date:
2010-05-01
